Nanoparticles that turn inflammation into propulsion power deliver targeted IBD treatment, enhancing precision and efficacy.

P13, a biosimilar of infliximab, in inflammatory bowel diseases: a systematic review and meta-analysis," published in the November 2024 issue of Gastroenterology by Hu et al. Since 2015, CT-P13, a ...

For Science Week, we’re hearing from some Irish-based researchers about this year’s theme of regeneration, including Dr Carol ...

Inc. , a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD) including ulcerative colitis, today announces that its lead clinical ...

This can lead to several gastrointestinal disorders, such as colon cancer, inflammatory bowel disease, cystic fibrosis ... University of California The results pave the way for prospective treatments ...

Shares of Avidity Biosciences surged to a record high Wednesday after the company showed its hand in the cardiovascular space.

There are many reasons someone may get sick frequently, from your environment and lifestyle to genetics and underlying ...

In November 1976, the United Arab Emirates was on a date with the birth of the Emirates News Agency, as a news and knowledge ...

Researchers using machine learning discovered that variations in microbial load in the gut, influenced by age, sex, diet, and more, play a significant role in disease-related bacterial presence. This ...

Researchers at Case Western Reserve University have identified a new target to treat atherosclerosis, a condition where ...

Colorectal surgeons evaluated the treatments available for patients with hemorrhoids at a conference in France.

In recent years, the role of gut microbiota has become the major area of focus in human health and diseases. Numerous studies have highlighted the importance of gut microbiota in the regulation of ...